U.S. Senate Misstep Will Cost Jobs and Slow Energy Production


By Jeff Stier

The Senate just failed to roll back an Obama-era regulation that will discourage energy production, cost millions of dollars, and kill thousands of American jobs.

The rule, issued in the eleventh hour of the Obama presidency by the Bureau of Land Management, was designed to limit already decreasing methane emissions from oil and natural gas wells on federal lands. The Republican-led Senate was expected to kill the regulation before it had a chance to take effect. But instead, three Republicans broke with their party to keep the rule in place.

That move was shocking. The environmental impact of the rule is essentially negligible. Methane only accounts for 10 percent of greenhouse gas emissions -- and federal lands host only 15 percent of natural gas production. Indeed, the rule would only trim CO2 emissions by less than 1/100th of 1 percent.

What's more, the industry already has a financial incentive to capture methane emissions -- and has been making great strides to reduce them. Between 1990 and 2015, according to the EPA, petroleum-related methane emissions fell more than 28 percent.

But Americans will have to pay a hefty price for this needless rule. One analysis predicts it could cost over $1.2 billion a year. Small businesses will feel the brunt of this financial burden. Small oil and gas producers are expected to dish out upwards of $64,000 each year to comply with the rule.

Some companies -- especially those operating a single well -- won't be able to handle such costs and may end up shutting down. In fact, according to consulting firm Environmental Resources Management, the methane rule could wipe out 40 percent of flaring wells on federal lands. When energy firms fold, Americans lose their jobs. Indeed, regulatory constraints oil and natural gas production, like this methane rule, could put 800,000 Americans out of work by 2020.

The rule will also reduce tax revenues. By discouraging natural gas production on federal land, it could pull $114 million out of federal and state coffers.

Western states, which host vast swaths of federal land, are particularly concerned about the rule's costs.

Utah's Public Lands Policy Coordinating Office says the rule "gives BLM authority without accountability and lacks proper cooperation with existing state regulatory agencies."

New Mexico Governor Susana Martinez maintains that, "Absent a repeal [of the methane rule], funding for New Mexico's schools, roads and healthcare will be dramatically reduced on account of the reduction in revenue generated by the oil and gas industry."

Her concern is warranted. New Mexico, which has energy development to thank for 30 percent of its state budget, could see 70 percent of its northwestern wells shut down.

In Rio Blanco, Colorado, where 85 percent of revenue is powered by oil and gas, market constraints on energy production have recently caused a 30 percent revenue dip. The methane rule will only worsen this financial blow.

All told, the methane rule could cost western America $9 million in economic output, royalties and wages.

Luckily, Kate MacGregor, the Interior Department's Acting Secretary, has stated that the agency is working to "suspend, revise, or rescind" the rule altogether.

It should. Doing away with the methane rule will protect American jobs and energy production. The sooner the Interior Department corrects the Senate's mistake, the better.

Jeff Stier is a senior fellow at the National Center for Public Policy Research in Washington, D.C., and heads its Risk Analysis Division.

More Resources


06/17/2024
What Biden and Trump Must Say To Win the Debate
In just under two weeks, President Joe Biden and Republican challenger former President Donald Trump will square off in the first of two televised debates, with immense implications for the 2024 presidential election.

more info


06/17/2024
The Moment Everyone Realized Biden's Not Fit for Office
When the last Democrat to occupy the White House has to literally grab the current one because he notices he's had yet another senior moment and appears to be paralyzed on stage, it h...

more info


06/17/2024
Dems Split Over Biden's Asylum Order
Some feel limiting US-Mexico border crossings will protect the country, while others say 'it violates American values'

more info


06/17/2024
Biden's Border Order Is Kabuki
Don't be fooled; stronger action is available without more laws.

more info


06/17/2024
GOP Looks to Trump To Turn Up Heat on Tester & Brown
Former President Trump is turning up the heat on Sens. Jon Tester (D-Mont.) and Sherrod Brown (D-Ohio) as Senate Republicans stand on the precipice of winning back the majority.

more info


06/17/2024
Historic Numbers of Black Voters Under 50 Giving Up on Dems
CNN's Harry Enten takes a look at polls showing black voters under 50 defecting from the Democratic Party.

more info


06/17/2024
How John Roberts Lost His Court
A self-described documentary filmmaker, trolling a gala dinner for a gotcha moment by engaging Supreme Court justices in conversation and surreptitiously recording their words, arguably scored with Justice Samuel Alito when he told her he shared their stated goal of returning "our country to a place of godliness."

more info


06/17/2024
Bar Group to Members: Don't Call Trump Verdict 'Partisan'
The Connecticut Bar Association is encouraging its members to speak out against public officials' criticism of the judicial system after former President Trump's recent convictions - and to perhaps think twice before offering their own opinions.

more info


06/17/2024
SCOTUS Controversy About More Than 'Appeal to Heaven'
Don't get caught up in the soap opera featuring the wife of a Supreme Court justice and the radical flags flying outside their home. The Alito controversy is about much more than a flag.

more info


06/17/2024
A Great Nothingburger: Rolling Stone's Hilarious Alito 'Scoop'
Supreme Court Justice Samuel Alito and his wife, Martha-Ann, are as controversial as the Pledge of Allegiance, or the phrase printed on all U.S. currency, "In God we Trust." Which is to say, they are not controversial at all.

more info


06/17/2024
We Invited Butker To Speak. We Won't Bow to Cancel Culture
The demand that we weigh in on Harrison Butker's speech is exactly the kind of problem Benedictine College hopes to counteract in American culture.

more info


06/17/2024
The Resistance To a New Trump Admin Has Already Started
An emerging coalition that views Donald J. Trump's agenda as a threat to democracy is laying the groundwork to push back if he wins in November, taking extraordinary pre-emptive actions.

more info


06/17/2024
How Left-Wing Conspiracies Work
When we hear such things in the months to come, remember that these mythologies are usually a warning: what the left is alleging is, quite often, precisely what the left is already doing.

more info


06/17/2024
Republican Rats Return to Trump's Ship
Trump's visit to the US Capitol - where the Republicans he almost got killed three years ago fawned over him - would be funny if it weren't pathetic

more info


06/17/2024
Don't Fall for Biden's Nice Old Man Act
Biden might act like a doddering incompetent, look like a wax effigy and walk like a robot, but the president has the uncanny ability to exceed all expectations when it counts, politically.

more info



Custom Search

More Politics Articles:

Related Articles

5 Financial Pressure Points To Evaluate During COVID Times


Financial pressure is a part of life for most people, and now the COVID-19 pandemic has brought new financial pressure points or exacerbated existing ones for many individuals and families.

Why Are People Complaining About Innovative COVID Treatments?


Gilead Sciences just announced it will charge $3,120 for a full course of Remdesivir, the first new FDA-approved treatment for COVID-19. Some knee-jerk members of Congress like Lloyd Doggett (D-Tex.) immediately condemned that price tag as "outrageous." The Institute for Clinical and Economic Review, a left-leaning nonprofit that releases its own recommendations of "fair" drug prices, claimed that Gilead could afford to price Remdesivir as low as $10 per course of treatment -- the cost of the raw ingredients used to make the drug.

Proposed Healthcare Reforms Will Not Help the Latinx Community


Joe Biden is officially the Democratic presidential nominee, all thanks to his moderate reputation.

Trade Enforcement Can Accelerate America's Economic Recovery


The stock market has largely rebounded from COVID-19 and American retail sales are improving steadily. Even more encouraging is that the U.S. unemployment rate fell for the fifth consecutive month in September. Each of these gains are sure signs that the Trump administration's economic response to the coronavirus crisis is working.

Drug Price Controls: Right Objective, Wrong Solution


This month, President Trump signed an executive order to reduce Medicare spending on prescription drugs. For each medication, Medicare will pay no more than the lowest price available in other developed countries.

Keep Thanksgiving, Family and Friends Alive


Joe Biden or Donald Trump will never visit me in my home, stand beside me at the funeral home or dance at my wedding. I will not be receiving any calls from either of them to pray for me during sickness or to check on how my children are doing. I probably will never sit in a room with them to visit, laugh and tell funny stories or just to hang out over a cup of coffee. I do not personally know either one. I welcome the opportunity to visit with either of them, but doubt it will happen.

The "E" Stands for “Excellence:” Remembering Walter E. Williams


Walter E. Williams, prolific author, piercing cultural commentator, old school economist (that’s a good thing), devoted husband, loving father, and long-time friend of Grove City College has passed from this world.

How Congress Can Really Fix Surprise Billing


House and Senate leaders recently agreed on legislation to end surprise medical bills as part of a big coronavirus relief package. President Trump signed it into law at the end of December.

A Federal Rule Will Reverse Strides in Cancer Treatment


"You've got cancer." That's one of the scariest sentences in the English language.

Biden Must Restore Seniors' Access to Essential Medicines


On January 19, Medicare officials announced a new payment model that could wreak havoc on the chronically ill.

Violence In America, Don't Be Surprised


The most recent attack at the United States Capitol will most likely insure a permanent fence and additional security. The attack which resulted in the loss of life for a long serving Capitol police officer and the attacker is another senseless violent act.

Protecting the Innovation that Protects Global Health


The most far-reaching healthcare policy decision of 2021 won't be made in Congress or the White House. It will be made at the World Trade Organization, which is considering a petition to waive all patent rights on Covid-19 vaccines.

Don't Repeat Europe's Vaccine Catastrophe


For many Americans, the calamitously slow vaccine roll-out in countries like Germany, France, and Italy comes as a surprise. After all, in the early days of the pandemic, Europe's response to the crisis seemed highly competent, especially compared to the United States.

A Full Plate for the New U.S. Trade Czar


The newly confirmed U.S. trade representative, Katherine Tai, is about as qualified as a person can be for the job. Which is a good thing, because she already faces a series of challenges.

Don't Let the US Import Europe's Failed Cancer Policies


With a majority in both the House and Senate and control of the Oval Office, Democratic leaders are excited about the prospect of making significant changes. One good example of this is the House Democrats' "Lower Drug Costs Now Act."